Table 4 Comparison of pregnancy outcomes between the cSLE and aSLE groups
Pregnancy outcomes | cSLE | aSLE | P value |
|---|---|---|---|
Foetal outcomes | N = 22 | N = 145 |  |
 Composite adverse foetal outcomes | 16 (72.7%) | 81 (55.9%) | 0.135 |
 Foetal loss | 8 (36.4%) | 31 (21.4%) | 0.122 |
 Foetal loss (without therapeutic/elective abortion) | 0/14 (0.0%) | 14/128 (10.9%) | 0.406 |
Live birth outcomes | N = 14 | N = 114 |  |
 Composite adverse live-birth outcomes | 8 (57.1%) | 50 (43.9%) | 0.346 |
 Preterm birth | 2 (14.3%) | 27 (23.7%) | 0.649 |
 Foetal distress | 1 (7.1%) | 2 (1.8%) | 0.296 |
 FGR | 1 (7.1%) | 9 (7.9%) | 1.000 |
 LBW | 4 (28.6%) | 33 (28.9%) | 1.000 |
 SGA | 4 (28.6%) | 24 (21.1%) | 0.764 |
 Asphyxiation | 2 (14.3%) | 9 (7.9%) | 0.764 |
Maternal outcomes | N = 14 | N = 114 |  |
 Composite adverse maternal outcomes | 8 (57.1%) | 38 (33.3%) | 0.080 |
 Active SLE | 7 (50.0%) | 19 (16.7%) | 0.010 |
 Active LN | 7 (50.0%) | 16 (14.0%) | 0.003 |
 HDP | 1 (7.1%) | 15 (13.2%) | 0.830 |
 GDM | 0 (0.0%) | 12 (10.5%) | 0.430 |
 PPH | 1 (7.1%) | 3 (2.6%) | 0.374 |